这是艾滋病治疗领域的首创。

FDA consumer Pub Date : 2006-11-01

{"title":"这是艾滋病治疗领域的首创。","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"The Food and Drug Administration has approved Atripla Tablets, a fixed-dose combination of three widely used antiretroviral drugs in a single tablet for the treatment of HIV-1 infection in adults. Atripla is to be taken once a day alone or in combination with other antiretroviral products.","PeriodicalId":76907,"journal":{"name":"FDA consumer","volume":"40 6","pages":"34"},"PeriodicalIF":0.0000,"publicationDate":"2006-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First of a kind in HIV treatment.\",\"authors\":\"\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The Food and Drug Administration has approved Atripla Tablets, a fixed-dose combination of three widely used antiretroviral drugs in a single tablet for the treatment of HIV-1 infection in adults. Atripla is to be taken once a day alone or in combination with other antiretroviral products.\",\"PeriodicalId\":76907,\"journal\":{\"name\":\"FDA consumer\",\"volume\":\"40 6\",\"pages\":\"34\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"FDA consumer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"FDA consumer","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

美国食品和药物管理局批准了Atripla片剂，这是一种固定剂量的三种广泛使用的抗逆转录病毒药物的组合，用于治疗成人HIV-1感染。Atripla每天一次单独服用或与其他抗逆转录病毒药物联合服用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

First of a kind in HIV treatment.

The Food and Drug Administration has approved Atripla Tablets, a fixed-dose combination of three widely used antiretroviral drugs in a single tablet for the treatment of HIV-1 infection in adults. Atripla is to be taken once a day alone or in combination with other antiretroviral products.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

FDA consumer

自引率

0.00%

发文量